semaglutide brain Weight loss linked to nerve cells in the Whole-brain activation signatures of weight-lowering

Plaintiffs lawyers will argue that Novo Nordisk had an obligation to warn even if the drug only slightly increased the baseline risk, especially since patients with diabetes are already vulnerable to ocular damage and would be even more cautious if fully informed

Its not just about losing weight its about keeping it off and feeling good while you do it

Diabetes Ther (2018) 9(6):231524

This study population was then divided into two cohorts: (1) Semaglutide cohort 254 patients prescribed semaglutide, and (2) non-GLP1-RA anti-diabetes medication cohort 7942 patients prescribed non-GLP-1RA anti-diabetes medications but not semaglutide

Mistake 3: ignoring the B12 component Some people treat the B12 in their compounded formulation as irrelevant window dressing